focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shareholder Update

11 Mar 2022 14:00

RNS Number : 5415E
Non-Standard Finance PLC
11 March 2022
 

Non-Standard Finance plc

 

('NSF', the 'Company' or the 'Group')

 

11 March 2022

 

Update on outstanding regulatory matters

As previously announced, the Group has been working to resolve certain outstanding regulatory matters so that it might then proceed with a substantial capital raise ('Capital Raise') that, if successful, would be used to fund customer redress as well as strengthen the Group's balance sheet and transform its prospects. Following recent developments, the Board is issuing the following update on these matters.

Independent regulatory reviews into branch-based lending and home credit

Having first agreed their scope with the FCA, independent reviews into both branch-based lending and home credit were initiated in 2021 to consider the read-across from the multi-firm review into guarantor loans and to ensure that recent decisions at the Financial Ombudsman Service were taken into account in assessing whether or not any customers may have suffered harm. 

Whilst the conclusion of the review into branch-based lending (Everyday Loans) was that there is no requirement for any customer redress, in home credit the conclusion was that there may have been harm and, following extensive discussions with the FCA about how this should be defined and the implications for future lending, the Directors of SD Taylor Limited (trading as 'Loans at Home') reluctantly concluded that the Loans at Home business is no longer viable and so have applied to the FCA to grant permission for Loans at Home to be placed into administration and to appoint insolvency practitioners from Grant Thornton UK LLP as administrators. The Boards of Loans at Home and of NSF are clear that this is the only option available in order to preserve value for creditors. As the operations and activities of Loans at Home are separate from the rest of the Group, the Board of NSF confirms that, having now agreed certain waivers with the Group's lenders, the administration of Loans at Home will have minimal impact on the rest of the Group's business.

Proposed redress methodology in guarantor loans

Following the FCA's detailed review of the Group's proposed redress methodology for certain customers of its guarantor loans business, the Group is continuing to work with the FCA on finalising the operational mechanics of the scheme. The board is hopeful that this will soon be finalised in order to provide certainty for investors so that it can then proceed with the Capital Raise that, if successful, will be used to fund customer redress as well as strengthen the Group's balance sheet and transform its prospects.

Planned capital raise

The Group intends to complete a substantial capital raise as soon as practicable and considering the regulatory developments detailed above, the Group is in discussions with its lenders to support this effort. The Group's largest shareholder, Alchemy Special Opportunities Fund IV L.P.('Alchemy'), has confirmed its continued support for the proposed Capital Raise. Alchemy's support remains subject to: an outcome of the Group's engagement with its lenders that is acceptable to Alchemy; Alchemy's analysis of the outcome of the Group's discussions with the FCA regarding the regulatory position of the Group's divisions and the implications of that on (and Alchemy's assessment of) the Group's business plan and financial projections; and greater levels of certainty around redress and claims.

If successful, the Capital Raise will reduce high levels of gearing, fund the payment of redress to certain customers of the Group and underpin the future growth of its lending operations. Should the Capital Raise be unsuccessful or take longer than expected to execute, then it is expected that the Group would remain in a net liability position from a balance sheet perspective, would breach certain borrowing covenants and as a result would likely not be able to access further funding over the period of breach and would require additional waivers from its lenders. In such circumstance, there would be a material risk of the Group going into insolvency. However, the Directors continue to believe there is a reasonable prospect of resolving this position.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The person responsible for making this announcement is the Director of IR and Communications.

 

Non-Standard Finance plc

Peter Reynolds, Director, IR and Communications

+44 (0) 20 3869 9026

 

Maitland/AMO

Neil Bennett

Finlay Donaldson

+44 (0) 20 7379 5151

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFVVVLILLIF
Date   Source Headline
10th Jul 20237:00 amRNSNotice of Delisting
7th Jul 20238:06 amRNSSuspension of Trading in Ordinary Shares
5th Jul 20233:18 pmRNSUpdate on Delisting and Suspension of Shares
23rd Jun 20232:51 pmRNSFiling of Annual General Meeting Resolutions
23rd Jun 20232:49 pmRNSResult of AGM
23rd Jun 20237:00 amRNSUpdate on Scheme, Delisting & Directorate Change
23rd May 20237:00 amRNSStandard form for notification of major holdings
18th May 20237:00 amRNSProposed Recapitalisation & Directorate Change 
28th Apr 20235:51 pmRNSReplacement: Update on scheme of arrangement
28th Apr 20233:33 pmRNSUpdate on scheme of arrangement
28th Apr 20238:21 amRNSAudited full year results to 31 December 2022
14th Apr 20237:00 amRNSProposed Release of Debt and Directorate Change
4th Apr 20234:14 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:39 amRNSLaunch of Scheme & Proposed Recapitalisation
17th Mar 20237:00 amRNSScheme of Launch & Proposed Recapitalisation
13th Feb 20237:00 amRNS2022 Trading Statement
4th Jan 202310:15 amRNSDirector/PDMR Shareholding
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20225:50 pmRNSDirector/PDMR Shareholding
29th Sep 20224:40 pmRNSSecond Price Monitoring Extn
29th Sep 20224:37 pmRNSPrice Monitoring Extension
28th Sep 20227:05 amRNSUpdate on Current Status and Regulatory matters
28th Sep 20227:05 amRNSUnaudited Half Year Results to 30 June 2022
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jul 20224:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:35 pmRNSPrice Monitoring Extension
6th Jul 20224:40 pmRNSSecond Price Monitoring Extn
6th Jul 20224:36 pmRNSPrice Monitoring Extension
4th Jul 20224:16 pmRNSDirector/PDMR Shareholding
15th Jun 20223:25 pmRNSFunding facilities update
26th May 20224:42 pmRNSFilings of AGM Resolutions
26th May 20222:49 pmRNSResults of Annual General Meeting
29th Apr 202212:00 pmRNSDirectorate Change
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
1st Apr 20224:40 pmRNSSecond Price Monitoring Extn
1st Apr 20224:35 pmRNSPrice Monitoring Extension
29th Mar 20229:26 amRNSDirector/PDMR Shareholding
17th Mar 20224:41 pmRNSSecond Price Monitoring Extn
17th Mar 20224:36 pmRNSPrice Monitoring Extension
16th Mar 20224:41 pmRNSSecond Price Monitoring Extn
16th Mar 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.